Onychomycosis: Health-related quality of life considerations

PharmacoEconomics

Volumn 20, Issue 1, 2002, Pages 23-36

  Shaw, James W ^a   Joish, Vijay N ^a   Coons, Stephen Joel ^a  

^a UNIVERSITY OF ARIZONA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FINGER NAIL; HUMAN; ONYCHOMYCOSIS; PRIORITY JOURNAL; PSYCHOMETRY; QUALITY OF LIFE; QUESTIONNAIRE; RATING SCALE; REVIEW;

EID: 0036177123     PISSN: 11707690     EISSN: None     Source Type: Journal    
DOI: 10.2165/00019053-200220010-00003     Document Type: Review

References (48)

1. Mycology of nail disorders
2. A multinational pharmacoeconomic analysis of oral therapies for onychomycosis
3. Clinical and economic factors in the treatment of onychomycosis
4. Pharmacoeconomic analysis of oral therapies for onychomycosis: A US model
5. Onychomycosis is more than a cosmetic problem
6. Quality of life of persons with onychomycosis
7. Measuring health-related quality of life in onychomycosis
8. The impact of onychomycosis on quality of life: Development of an international onychomycosis-specific questionnaire to measure patient quality of life
9. Effect of onychomycosis on quality of life
10. Quality of life issues for patients with fungal nail infections
11. A pilot study to determine the biopsychosocial effects of onychomycosis on a northeastern American subpopulation
12. The impact of onychomycosis on quality of life
13. The effect of toenail onychomycosis on patient quality of life
14. Achilles Foot-Screening Project: Background, objectives and design
15. Achilles Foot-Screening Project: Preliminary results of patients screened by dermatologists
16. Patients' feelings and attitudes about their nail conditions
17. Onychomycosis: Baseline results of an observational study
18. A health-related quality of life measure for use in patients with onychomycosis: A validation study
19. Health-related quality of life in patients with toenail onychomycosis: Data from a 9-month observational study
20. Measuring the impact of onychomycosis on patient quality of life
21. Efficacy of terbinafine for toenail onychomycosis: A multicenter trial of various treatment durations
22. Quality of life for patients with onychomycosis
23. Physical attractiveness, happiness, neuroticism, and self-esteem
24. Onychomycosis: A significant medical disorder
25. A comparative review of generic quality-of-life instruments
26. Evaluating quality of life and health status instruments: Development of scientific review criteria
27. Quality-of-life assessment in diabetes research: Interpreting the magnitude and meaning of treatment effects
28. Coefficient alpha and the internal structure of tests
29. Intraclass correlations: Uses in assessing rater reliability
30. The dimensionality of self-esteem. II: Hierarchical facet models for revised measurement scales
31. A 12-Item Short-Form Health Survey: Construction of scales and preliminary tests of reliability and validity
32. The psychological general well-being (PGWB) index
33. Management of onychomycosis
34. Onychomycosis: Current treatment and future challenges
35. Generic and disease-specific measures in assessing health status and quality of life
36. Barriers to the use of health status measures in clinical investigation, patient care, and policy research
37. On the generalizability of statistical expressions of health related quality of life instrument responsiveness: A data synthesis
38. Measuring health-related quality of life
39. Responsiveness in quality-of-life assessment: Nomenclature, determinants, and clinical applications
40. Auranofin therapy and quality of life in patients with rheumatoid arthritis: Results of a multicenter trial
41. General versus disease-specific measures: Further work on the Sickness Impact Profile for head injury
42. US regulation of pharmaceutical outcomes research